cladribine

This page shows the latest cladribine news and features for those working in and with pharma, biotech and healthcare.

Sanofi licences Principia MS drug in $805m deal

The three established players in the oral MS therapy category are also about to see additional competition from new entrant Merck KGaA, which bagged EU approval for Mavenclad (cladribine) in August.

Latest news

Merck mulls sale of consumer health division

The news comes a few days after Merck picked up an important new approval for its pharma division in Europe, with the EMA clearing Mavenclad (cladribine) for the treatment of
Merck gets CHMP backing for long-delayed oral MS drug

Follow-up studies also revealed that oral cladribine could be stopped in year three and four without an increase in relapses. ... The company thinks oral cladribine has a key differentiator from its rivals, which require daily dosing.
Avelumab costs peg back profit at Merck KGaA

Avelumab and other pipeline candidates such as oral MS therapy cladribine have assumed even more importance for Merck since it abandoned plans to seek approval of evofosfamide in advanced soft tissue
Merck's pharma unit faces tougher 2017 as fertility boost recedes

Top of that list is oral MS therapy cladribine, which was submitted for approval in the EU in June, and according to Kuhnert is proceeding through regulatory review as expected.
Merck sees €2bn from new launches by 2022

Other than avelumab, Merck has just two other candidates in late-stage development, namely oral cladribine for multiple sclerosis (MS) and a biosimilar of AbbVie's TNF inhibitor Humira (adalimumab). ... Cladribine is closest to market having already been

More from news
Approximately 2 fully matching, plus 25 partially matching documents found.

Latest appointments

XenoPort appoints chief medical officer

Prior to joining Biogen Idec Dr Kim was with Merck Serono, serving as medical director for the phase III programme of cladribine, which failed to impress in MS.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Manager: Negotiable

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Systematic Review Lead- London: Negotiable

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Account Director or Senior Account Director: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Manager- 4 days per week or full-time: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Training Manager - Surrey: Competitive Salary &Bonus

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Healthcare PR Senior Account Manager: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

The gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...